Evidence map›Paper›PMID 22145019›Full record

ArticlePloS one2011

Localization of ASV integrase-DNA contacts by site-directed crosslinking and their structural analysis.

Elena Peletskaya, Mark Andrake, Alla Gustchina, George Merkel, Jerry Alexandratos, Dongwen Zhou, Ravi S Bojja, Tadashi Satoh, Mikhail Potapov, Alex Kogon and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. C-Terminal Domain of Integrase Binds between the Two Active Sites.Journal of chemical theory and computation · 2015
    Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Elena PeletskayaBiolinx LLC, Alburgh, Vermont, United States of America.
Mark Andrake
Alla Gustchina
George Merkel
Jerry Alexandratos
Dongwen Zhou
Ravi S Bojja
Tadashi Satoh
Mikhail Potapov
Alex Kogon
Viktor Potapov
Alexander Wlodawer
Anna Marie Skalka
Fox Chase Cancer Center · USCenter for Cancer Research · USInstitute of Bioorganic Chemistry · RUNational Cancer Institute · USNational Institutes of Health · USRussian Academy of Sciences · RU

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
Protein StructureZIABC010348 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WLODAWER, ALEXANDER · 2009 to 2025
$27.5M
INTEGRATION OF RETROVIRAL DNA--ACCESSING HOST TARGET DNAR01CA071515 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI KATZ, RICHARD ALAN · 1996 to 2016
$7.6M
STRUCTURE/FUNCTION OF INTEGRASER01AI040385 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI ANDRAKE, MARK DAVID · 1997 to 2016
$7.1M
Crosslinking stabilization of integrase-DNA complexesR21AI064098 · NIAID · BIOLINX, LLC · PI PELETSKAYA, ELENA N · 2005 to 2006
$278k
Intramural NIH HHSNCI NIH HHS CA06927NCI NIH HHS CA71515NCI NIH HHS P30 CA006927NCI NIH HHS R01 CA071515NIAID NIH HHS AI064098NIAID NIH HHS AI40385NIAID NIH HHS R01 AI040385NIAID NIH HHS R21 AI064098
6 · The paper itself

Abstract

backgroundWe applied crosslinking techniques as a first step in preparation of stable avian sarcoma virus (ASV) integrase (IN)-DNA complexes for crystallographic investigations. These results were then compared with the crystal structures of the prototype foamy virus (PFV) intasome and with published data for other retroviral IN proteins. METHODOLOGY/

resultsPhotoaffinity crosslinking and site-directed chemical crosslinking were used to localize the sites of contacts with DNA substrates on the surface of ASV IN. Sulfhydryl groups of cysteines engineered into ASV IN and amino-modified nucleotides in DNA substrates were used for attachment of photocrosslinkers. Analysis of photocrosslinking data revealed several specific DNA-protein contacts. To confirm contact sites, thiol-modified nucleotides were introduced into oligo-DNA substrates at suggested points of contact and chemically crosslinked to the cysteines via formation of disulfide bridges. Cysteines incorporated in positions 124 and 146 in the ASV IN core domain were shown to interact directly with host and viral portions of the Y-mer DNA substrate, respectively. Crosslinking of an R244C ASV IN derivative identified contacts at positions 11 and 12 on both strands of viral DNA. The most efficient disulfide crosslinking was observed for complexes of the ASV IN E157C and D64C derivatives with linear viral DNA substrate carrying a thiol-modified scissile phosphate.

conclusionAnalysis of our crosslinking results as well as published results of retroviral IN protein from other laboratories shows good agreement with the structure of PFV IN and derived ASV, HIV, and MuLV models for the core domain, but only partial agreement for the N- and C-terminal domains. These differences might be explained by structural variations and evolutionary selection for residues at alternate positions to perform analogous functions, and by methodological differences: i.e., a static picture of a particular assembly from crystallography vs. a variety of interactions that might occur during formation of functional IN complexes in solution.

Indexed as

Amino Acid SequenceAvian Sarcoma VirusesBase SequenceBinding SitesCross-Linking ReagentsCrystallography, X-RayDNA, ViralIntegrasesLightModels, ChemicalModels, MolecularMolecular Sequence DataMutagenesis, Site-DirectedMutationProtein ConformationSequence Homology, Amino AcidCross-Linking ReagentsDNA, ViralIntegrases

Identifiers

PMID22145019
PMCPMC3228729
OpenAlexW2077095206

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.